Trails Edge Capital Partners, LP: VAXCYTE INC (PCVX): Quarterly 13F Position History
As of Q1 2026, Trails Edge Capital Partners, LP reported 662,470 shares of VAXCYTE INC (PCVX), worth $38.5M and representing 9.1% of its 13F equity book. Quarter-over-quarter share count change: 75,000 (-10.2%) . The position first appeared in Q4 2025 and has been disclosed across 2 13F-HR filings in Pactolio's tracked window.
- 662,470Shares Held (Latest Filing)
- $38.5MReported Market Value (Latest Filing)
- 9.1%Portfolio Weight (% of 13F Equity Book)
- 75,000Quarter-over-Quarter Share Change
- +$4.5MQuarter-over-Quarter Value Change
- 737,470Peak Reported Shares (Historical)
Recent initiation: Trails Edge Capital Partners, LP first reported PCVX on the Q4 2025 filing — fewer than three quarters of history are available.
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 2 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 662,470 | 75,000 | -10.2% | $38.5M | 9.1% | $58.1 |
| Q4 2025 | 737,470 | — | — | $34.0M | 8.4% | $46.1 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did Trails Edge Capital Partners, LP first disclose a PCVX position in 13F-HR filings?
Trails Edge Capital Partners, LP first reported VAXCYTE INC (PCVX) on its 13F-HR filing for the period ending 2025-12-31 (Q4 2025). The position has appeared on 2 reported quarters within Pactolio's tracked window.
What was Trails Edge Capital Partners, LP's most recent quarter-over-quarter share-count change in PCVX?
Between Q4 2025 and Q1 2026, Trails Edge Capital Partners, LP reduced its PCVX position by 75,000 shares (-10.2%), leaving 662,470 shares at a market value of $38.5M.
Does the implied price-per-share represent Trails Edge Capital Partners, LP's cost basis in PCVX?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.